PharmaSynth is specialized in supplying precursors and standards for PET and SPECT imaging, following GMP guidelines. Our product list contains already more than 100 molecules for many different target systems. The largest share (more than 80% of the products) goes to neuroscience molecules, as our knowledge and expertise prospers in this area. However, we continuously develop our portfolio to satisfy our customer's variable needs. As a result, we offer an expanding selection of products used in oncology, cardiology and other applications such as endocrine disorders.
| Website | http://www.pharmasynth.ee |
| Revenue | $1 million |
| Employees | View employees |
| Address | 7 Teaduspargi, Tartu, Tartu, EE |
| Phone | +372 747 5620 |
| Fax | (372) 738-3041 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Roche, Novartis, Boehringer Ingelheim, Pfizer, Merck & Co., Inc., GSK, AbbVie, AstraZeneca, Sanofi, Bristol Myers Squibb +45 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular PharmaSynth AS employee's phone or email?
PharmaSynth AS Questions
The PharmaSynth AS annual revenue was $1 million in 2026.
PharmaSynth AS is based in Tartu, Tartu.
The NAICS codes for PharmaSynth AS are [3254, 32, 32541, 325].
The SIC codes for PharmaSynth AS are [283, 28].
